Radiotherapy WAITING TIME RELATIONSHIP WITH THE QUALITY OF LIFE OF CANCER PATIENTS REPRODUCTIVE SYSTEM IN GENERAL HOSPITAL CENTER DR. Sardjito
ABSTRACT: Background :. The reproductive system cancer incidence in Indonesia was increased, from 40-45 new cases for every day, who died as many as 20-25 people, among them are in the productive age. One option treatment is radiotherapy , which has a fairly long waiting time. Delay radiotherapy can have a negative impact on the patient . The impact of cancer and waiting times for radiotherapy can reduce the quality of life of the reproductive system cancer. Objective : This research was aimed to determined correlation between waiting times for radiotherapy with the quality of life reproductive system cancer patient at the Sardjito Hospital Yogyakarta. Method : This research was conducted cross sectional approach which purposive sampling technic to 40 reproductive system cancer patient at the Sardjito Hospital Yogyakarta. Measurement of quality of life using EORTC QLQ-C30 from WHO in Indonesian version. Measurement of waiting times for radiotherapy that collect from medical record patient as secondary data. Analysis of data as descriptive, Chi-Square tes and multivariable analysis using Logistic Regression. Results : A total of 33 (82.5%)respondents had a long waiting times radiotherapy is > 8 month. A total of 35(87.5%)respondents have a lower quality of life with <= 75 score. Statistical analysis showed that significant value between both variable more than 0.05 (p=1.00), with RR (95% CI) value 1.199; 0068-21.26. This data are clinically meaningfull, that patients with faster waiting times had 1.199 times chances to increase quality of life, but statistically have a very weak relationship. Conclussion : Waiting times for radiotherapy of reproductive system cancer patient has a long times. Quality of Life reproductive system cancer patient is low. There is a clinically significant association between radiotherapy waiting times with the quality of life of reproductive system cancer patients, but statistically not significant.